Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity.

Huber EM, Basler M, Schwab R, Heinemeyer W, Kirk CJ, Groettrup M, Groll M.

Cell. 2012 Feb 17;148(4):727-38. doi: 10.1016/j.cell.2011.12.030.

2.

Role of proteasomes in antigen presentation.

Gaczynska M, Rock KL, Goldberg AL.

Enzyme Protein. 1993;47(4-6):354-69. Review.

PMID:
7697133
3.

The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.

Sijts A, Zaiss D, Kloetzel PM.

Curr Mol Med. 2001 Dec;1(6):665-76. Review.

PMID:
11899255
4.

The immunoproteasome in antigen processing and other immunological functions.

Basler M, Kirk CJ, Groettrup M.

Curr Opin Immunol. 2013 Feb;25(1):74-80. doi: 10.1016/j.coi.2012.11.004. Epub 2012 Dec 6. Review.

PMID:
23219269
5.

The proteasome activator 11 S REG (PA28) and class I antigen presentation.

Rechsteiner M, Realini C, Ustrell V.

Biochem J. 2000 Jan 1;345 Pt 1:1-15. Review.

6.

Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.

Persson K, Schneider G.

Arch Immunol Ther Exp (Warsz). 2000;48(3):135-42. Review.

PMID:
10912617
7.

Emerging roles of immunoproteasomes beyond MHC class I antigen processing.

Ebstein F, Kloetzel PM, Krüger E, Seifert U.

Cell Mol Life Sci. 2012 Aug;69(15):2543-58. doi: 10.1007/s00018-012-0938-0. Epub 2012 Mar 2. Review.

PMID:
22382925
8.

Diversity of proteasomal missions: fine tuning of the immune response.

Borissenko L, Groll M.

Biol Chem. 2007 Sep;388(9):947-55. Review.

PMID:
17696779
9.

Immunoproteasomes: structure, function, and antigen presentation.

Ferrington DA, Gregerson DS.

Prog Mol Biol Transl Sci. 2012;109:75-112. doi: 10.1016/B978-0-12-397863-9.00003-1. Review.

10.

The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.

Niedermann G, Geier E, Lucchiari-Hartz M, Hitziger N, Ramsperger A, Eichmann K.

Immunol Rev. 1999 Dec;172:29-48. Review.

PMID:
10631935
11.
12.

Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation.

Young AC, Nathenson SG, Sacchettini JC.

FASEB J. 1995 Jan;9(1):26-36. Review.

PMID:
7821756
13.

Proteasome and class I antigen processing and presentation.

Belich MP, Trowsdale J.

Mol Biol Rep. 1995;21(1):53-6. Review.

PMID:
7565665
14.

Subunit specific inhibitors of proteasomes and their potential for immunomodulation.

Kisselev AF, Groettrup M.

Curr Opin Chem Biol. 2014 Dec;23:16-22. doi: 10.1016/j.cbpa.2014.08.012. Epub 2014 Sep 15. Review.

15.

Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases.

Ettari R, Previti S, Bitto A, Grasso S, Zappalà M.

Curr Med Chem. 2016;23(12):1217-38. Review.

PMID:
26965184
16.

[Diversity of proteasomes in mammals and its biological significance].

Murata S.

Seikagaku. 2008 Aug;80(8):719-32. Review. Japanese. No abstract available.

PMID:
18807497

Supplemental Content

Support Center